NFKB1 and COVID-19: Based on the results of core signaling analyses and considering relative protein/gene expression levels as compared with normal nasopharyngeal tissues [58], we choose TNF, NFkB, and HIF1A as common biomarkers (drug targets) of infections pathogenesis in both COVID-19-associated ARDS and non-viral ARDS.